Andy Herbert has worked in the biotechnology industry internationally for more than 30 years. He has a detailed knowledge of pharmaceutical manufacturing, GMP, process and product development.
After receiving a doctorate in biochemical engineering sponsored by Unilever in the UK in 1984 he worked for five years in process development in ICI’s industrial fermentation and biochemicals division. He moved to Canada in 1989 and spent nine years with Sanofi-Pasteur, ultimately taking responsibility for all vaccine development in Canada. He was part of teams that developed and licensed a highly effective acellular pertussis vaccine and the human cancer vaccine ImmuCyst®, for the treatment of superficial bladder cancer.
In 1998 he founded a biopharmaceutical engineering consulting company in Toronto and over the next eight years built a team which has assisted more than 30 different biotechnology client companies in Canada, USA, Mexico, Cuba and Argentina.
After moving to New Zealand in 2005 he took a role as General Manager Operations with ICPbio Ltd., leaving the firm in 2007 to set up as an independent consultant to biotechnology companies.
Based in Nelson, Andy works with a range of New Zealand and overseas companies including those developing pharmaceuticals, nutraceuticals, food ingredients, new processing technologies and services. As well as project-based consulting, he has taken on roles within companies that include Chief Science Officer (Nutrizeal, NZ), Vice-President Product and Process Development (Polybatics, NZ), Head of Pharmaceutical Operations (Ondek Pty, Australia).